Bridging Innovative RNA Biology and Drug Discovery
Our mission:
By combining multidisciplinary academic innovators with biotech-inspired objectives and focus, our goal is to uncover novel disease solutions by advancing the science of RNA regulation, developing new technological platforms, and discovering early-stage therapeutics.
Our Approach:
Recruit and nucleate current and next generation leaders in RNA biology and cultivate environment of collaboration, technology innovation and entrepreneurship
Build multi-disciplinary drug discovery teams focused on translating transformative RNA discoveries into therapeutics utilizing biotech best practices
Integrate academic innovators with therapeutic teams to bridge the gap between discovery and clinically applicable therapies
CENTER Happenings
recent media & publications
Congrats to Joey Song, Dr. Eric Van Nostrand, and colleagues for their Genome Biology publication “Mapping snoRNA-target RNA interactions in an RNA-binding protein-dependent manner with chimeric eCLIP”
Dr. Steven Boeynams received the NIH Director's New Innovator Award to study how neuropathology mimics infectious disease and how the innate immune system responds. Congrats!
Congratulations to Dr. Trey Westbrook and Dr. Jitendra Meena on their recent publication “MYC Induces Oncogenic Stress through RNA Decay and Ribonucleotide Catabolism in Breast Cancer” in Cancer Discovery!
upcoming events
THINC Seminar Series has ended for the academic year. Check back soon for information on next year’s series!
RNA Group has ended for the academic year. Thanks to all those that presented and attended! Check back soon for information on next year’s series!